Last update 24 Nov 2025

JYP-0035

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
JYP 0035, JYP-0035, JYP0035
Target
PI3Kα
Action
inhibitors
Mechanism
PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Advanced Malignant Solid NeoplasmPIK3CA mutant Breast Cancer
Inactive Indication-
Originator Organization
Jiayue (Chengdu) Pharmaceutical Technology Co., Ltd.
Active Organization
Jiayue (Chengdu) Pharmaceutical Technology Co., Ltd.Guangzhou Jiayue Pharmaceutical Technology Co., Ltd.Guangzhou Jiayue Pharmaceutical Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JYP-0035
NCT06158477
/ RecruitingPhase 1
An Open-label Multicenter, Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors
100 Clinical Results associated with JYP-0035
Login to view more data
100 Translational Medicine associated with JYP-0035
Login to view more data
100 Patents (Medical) associated with JYP-0035
Login to view more data
100 Deals associated with JYP-0035
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Guangzhou Jiayue Pharmaceutical Technology Co., Ltd.Guangzhou Jiayue Pharmaceutical Technology Co., Ltd.
01 Jan 2024
PIK3CA mutant Breast CancerIND Approval
China
Jiayue (Chengdu) Pharmaceutical Technology Co., Ltd.
17 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free